- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
0 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €352.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.94
7D
2.3%
1Y
-25.5%
Heidelberg Pharma
Market Cap: €122.1m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, Europe, China, the United States, and internationally.
HPHA
€2.61
7D
0.4%
1Y
-34.8%
Darwin
Market Cap: €95.4m
Operates in the healthcare industry.
7V0
€7.95
7D
32.5%
1Y
n/a
Cantourage Group
Market Cap: €76.1m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€6.10
7D
-1.6%
1Y
3.7%